about
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune,...
Read More
2.41
0.06
(2.55%)
630.9K
XNAS Volume
XNAS 22 Aug, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
INmune Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..